Project Grant R03TR005599
Award Date
6/1/25
Completion Date
5/31/26
Dollars Obligated
$148K
Federal Agency
National Center for Advancing Translational Sciences
Federal Grant Program
93.350
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
This $780,000 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under CFDA 93.859 Biomedical Research and Research Training Program will support research to develop new computational tools and methodologies for accurately predicting the functional effects of genetic mutations, with a focus on the chromatin remodeling enzyme SMARCA4. The goal is to improve the interpretation of human genetic variations and enhance the ability to diagnose and treat diseases,...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to investigate the mechanisms underlying the regulation of the phosphate transporter SLC20A1 and more broadly, phosphate homeostasis and sensing. The $410,000 grant awarded to the University of Texas Southwestern Medical Center will fund three synergistic research projects over 5 years starting August 1, 2024. The...
This federal Project Grant award, funded by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $249,000 over 3 years (9/1/2024 - 8/31/2027) to the University of Kansas Center for Research Inc. to conduct research on identifying new therapeutics and molecular mechanisms for Congenital Disorders of Glycosylation (CDGs). The key objectives of this research project are to: 1) Determine the...
This Project Grant award, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to determine the causality and pathophysiological significance of human SEL1L and SYVN1 genetic variants and elucidate the underlying molecular mechanisms. The total funding amount is $654,844, with an award date of February 3, 2025, and an ultimate completion...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $275,100 to fund research focused on understanding the structure and function of proteins involved in intracellular transport within human cells. The research will utilize nuclear magnetic resonance (NMR) spectroscopy and other biophysical methods to investigate how structurally disordered regions of proteins, such as the dynein...
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $225,101.00 to investigate the mechanisms underlying the increased risk of hematological malignancy in sickle cell disease (SCD). The project, titled "MECHANISMS UNDERLYING INCREASED RISK OF HEMATOLOGICAL MALIGNANCY IN SICKLE CELL DISEASE", aims to: Perform experiments to study the impact of oxidative stress-induced DNA damage on the development of clonal hematopoiesis...
This federal Project Grant award, funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859), supports research to enhance the understanding of the genetic basis of complex trait variation. The $423,750 award to New York University School of Medicine, with a project period from May 1, 2025 to March 31, 2030, will focus on three key aims: Developing new approaches to identify the genes that contribute most to...
The National Institute of General Medical Sciences (NIGMS) awarded a $421,600 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the Morgridge Institute for Research, Inc. to investigate the interplay of genetic and environmental factors that influence human cell fitness. The project aims to: 1) understand context-dependent genetic contributions to cell growth, 2) examine physiologic nutrient dependencies, and 3) delineate environmental contributions to T cell fitness....
This federal Project Grant award for $198,750.00 from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) aims to develop conditional animal models of mitochondrial DNA diseases. The project seeks to use CRISPR gene editing tools to introduce precise edits in the mitochondrial genome of zebrafish, enabling the creation of the first conditional animal model for mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). This...
This $451,000 Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), supports research to investigate the molecular mechanisms regulating the expression and activity of the calcium transporter SLC24A4 in ameloblasts during enamel formation. The two key objectives are: 1) Determine the developmental cues and epigenetic factors that upregulate SLC24A4 transcription in maturation ameloblasts,...